Frequency, nature and risk factors of lesions of the esophagogastroduodenal zone in patients with bronchial asthma
https://doi.org/10.31146/1682-8658-ecg-176-4-54-58
Abstract
The questionnaire screening of patients with bronchial asthma showed that the majority of patients do not focus on existing complaints from the digestive organs and refer them to manifestations of their underlying disease. Esophagogastroduodenalfi broscopic examination of patients with asthma for the fi rst time refl ected the presence of Esophagogastroduodenal zone (EGDZ) pathology in 67.3% of patients, of which erosive-ulcerative lesions were detected in 21.3% of cases and catarrhal lesions — in 46% of cases. It is necessary to pay attention to the fact that the resolving factors for the development of the pathology of the Esophagogastroduodenal zone in patients with bronchial asthma are behavioral factors — smoking, drinking alcohol, strongly cooled drinks and violation of the safe use of the inhaler, creating serious prerequisites for the development of this pathology. The high frequency of EGDZ lesions in patients with bronchial asthma correlates with the duration of administration and doses of glucocorticosteroid therapy, which emphasizes its role as a trigger for the development of the pathology of the Esophagogastroduodenal zone.
About the Authors
M. T. Rustamova
Tashkent medical academy
Uzbekistan
Tashkent
Uzbekistan
Tashkent
I. V. Liverko
Tashkent medical academy
Uzbekistan
Tashkent
Uzbekistan
Tashkent
S. S. Khayrullaeva
Tashkent medical academy
Uzbekistan
Tashkent
Uzbekistan
Tashkent
B. Sаhova
Tashkent medical academy
Uzbekistan
Tashkent
Uzbekistan
Tashkent
References
1. Barnes P.J, Adcock I. M. How do corticosteroids work in asthma. Ann. Intern. Med. 2003, vol. 139, pp. 359–370.
2. Bor S, Kitapcioglu G, Solak Z. A. et al. Prevalence of gastroesophageal reflux disease in patients with asthma and chronic obstructive pulmonary disease. Jоrnal Gastroenterol. Hepatol. 2010; 25(2):309–313.
3. Field S. K. A critical review of the studies of the effects of simulated or real gastroesophageal reflux on pulmonary function in asthmatic adults. Chest. 2009; 115:848–56.
4. Global Initiative for Astma, all rights reserved. Use is by express license from the owner, 2014.
5. Hansen R.A., Tu W., Wang J. et al. Risk of adverse gastrointestinal events from inhaled-corticosteroids. Pharmacotherapy. 2008, no. 28(11), pp. 1325–1334.
6. Storonova O.A., Trukhmanov A. S., Dzhakhaya N. L. et al. Disorders of esophageal clearance at gastroesophageal reflux disease and options of their treatment. Ros. Jurn. gastroenterol. gepatol. koloproktol., 2012, vol. 22, no. 2, pp. 14–21.
7. Burkov S. G., Alekseeva E. L., Yurenev G. P., Aru tyunov A. N. Klinicheskoe techenie, diagnostika i lechenie gastroesophagealnoi refluxnoi bolezni, assozirovannoi s bronchialnoi asthmoi [The clinical course, diagnosis and treatment of gastroesophageal reflux disease associated with bronchial asthma]. Pharmateka, 2007, no. 6, pp 38–43.
8. Galimova E. S., Nurtdinova G. M., Kucher O. I. et al. Klinicheskie aspekti nekotorih naibolee rasprostranennih sochetanii bronchialnoi astmi s zabolevaniyami organov bryuschnoi polosti (obsor literaturi). – Fundamentalnie issledovaniya [Clinical aspects some of the most common combinations of bronchial asthma with diseases of the abdominal organs (literature review)]. Basic research, 2010, no. 4, pp 26–35.
9. Geppe N. A., Kolosova N. G. Besopasnost i effektivnost – osnova vibora ingalyacionnih GKS v terapii bronchialnoi asthmi u detei [Safety and effectiveness – the basis for the choice ofi nhaled corticosteroid the treatment of bronchial asthma in children]. Pulmonologiya, 2013, no. 1, pp. 86–89.
10. Zvyaginseva N. D., Chernobai A. I. Gastroesophagealnaya refluxnaya bolezn v sochetanii s bronchialnoi asthmoi: obschnost patogeneza i taktika lecheniya. Novosti medicini i pharmacii. [Gastroesophageal reflux disease in combination with bronchial asthma: common pathogenesis and treatment tactics]. News of medicine and pharmacy, 2010. – URL: http://novosti.mif-ua.com/archive/issue-12445/article-12452/ (Accessed: 4.01.2013).
11. Kirillov S. M. Osobennosti patologii pischevaritelnoi sistemi u bolnich bronchialnoi asthmoi i chronicheskoi obstructivnoi boleznyu legkih: Avtopef. diss. d-ра med. nauk [Features of the pathology of the digestive system in patients with bronchial asthma and chronic obstructive pulmonary disease: Abstract. diss. Dr. med. Science.] S-Petersburg, 2008, 46 p.
12. Paleev N. R., Isakov V. A., Chereiskaya N. K. et al. Vliyanie gastroeso-phagealnoi refluxnoi bolezni na techenie bronchialnoi asthmi u pogilih [The effect of gastroesophageal reflux disease on the course of bronchial asthma in the elderly]. http: www.gastroscan.ru, 2011. Section: pulmonology, phthisiology.
13. Ubaidullaev A. M., Liverko I. V., Аbdullaev V. A. et al.. Corticozavisimost i corticorezistentnost u bolnih bronchialnoi asthmoi [Cortical dependence and corticostasis in patients with bronchial asthma]. Vestnik Associacii pulmonologov Centralnoi Asii, 2010, no.3–4, pp.162–163.
14. Chernyavskaya G. M., Maksimenko G. V., Be lo bo ro dova E. I. et al. Кlinico-morphologicheskie оsobennosti techeniya yazvenn bolezni dvenadzatiperstnoi kischki pri bronchialnoi asthme [Clinical and morphological features of the course of duodenal ulcer in bronchial asthma] J. Clin.medicin. 2014, no. 2, pp.47–52.
Review
For citations:
Rustamova M.T., Liverko I.V., Khayrullaeva S.S., Sаhova B. Frequency, nature and risk factors of lesions of the esophagogastroduodenal zone in patients with bronchial asthma. Experimental and Clinical Gastroenterology. 2020;174(4):54-58. (In Russ.) https://doi.org/10.31146/1682-8658-ecg-176-4-54-58
Views:
361
Email this article 